Good morning. Yeah, good morning, everyone and welcome to the Women in Tech Global Conference. Our session today is hosted by Uncle Body Technologies Limited and we are a digital health innovation company that is empowering confident cancer care decisions for patients, clinicians and leading healthcare companies.

And we are excited to have you all here. Join us in this session today and thank you for your commitment to improving cancer care in lower middle income countries. I am Doctor Adora A and I'll be your moderator for the session today. And our session today is titled Last Mile Cancer Technologies, improving cancer survival rates in low and middle income countries. Now, I have the slider link uh because we, we love polls at Uncle Paddy and it's just a quick poll for you to share with us. Um Why you are attending this session? We just want to know um your basic understanding now to provide a bit of context to our discussion today. Last my cancer technologies refers to innovations that deliver cancer um care products directly to patients regardless of their geographic locations and these innovations are provided to end users. Now, one thing you must know is that there is a global shortage of oncology professionals and resources, especially across lower and middle income countries. This notable shortage has resulted in significant health care disparities. For example, in Nigeria, we have 18, only 18 out of the six days have a clinical oncologist and as such, um the burden is increasing every year, each year.

Um lower and middle income countries each year, cancer deaths recorded are about 9 million cases and lower and middle income countries alone contribute to about 72% of these and death. And so um to talk more about this topic, um this topic that is very dear to us. I want to introduce my amazing speakers um who are um trail builders by their, by their right. They are global innovators and researchers who are committed to generating evidence and solution. So, first off, I have Professor Wilfred Ngu and professor W is a professor of Global Health.

He is also the founding director of the Global Health Catalyst. Um Doctor Will is an Associate Professor of Radiation Oncology at John Hopkins Medicine in the United States of America and he's also the Chair of Lancet Oncology Commission for Sub Saharan Africa. Welcome, Doctor Will.

Next I have Dr Mattie as Doctor Matthew Aso is an expert on digital health for people living with advanced cancer. Doctor Matthieu is an Associate Professor of Palliative Care School of Medicine University of Leeds in the United Kingdom. His research explores the development of palliative care services with a focus on the role of technology, primary in the UK in Indonesia and so many other countries in Sub Sah Africa. You're welcome, Doctor Matthew. And next up, I have Doctor Moola Salako. Doctor Mole Salako would educate us on mobile health research and data intelligence in oncology. Doctor Mola Salako is a lecturer at the RBRR digital Health Hub in the College of Medicine University of Lagos Nigeria. She's also a clinical and radiation oncologist and she's the founder of Shebeli Cancer Care Pill Oncology and the Onco Body app. You're welcome, Doctor Salako. All right. So we would like to know from our audience how familiar which you are with this topic that we are about to discuss today. Our goal for our session is really to reflect on the potential benefits of last my cancer technologies and to get us started. Um Doctor Matteo, I would like to ask, um can you, I know you've led a multi country qualitative discussion, qualitative study in three African countries that access the digital health needs of cancer patients.

Can you highlight for us your research findings or mobile phone based interventions and how they can be used to deliver cancer care directly to patients irregardless of their geographic location.

Yeah, absolutely. Thank you very much, Adam. And it's uh it's, it's great to be here really um really privileged to be able to talk today and uh just to pick up on the point you made in the introduction, there are increasing numbers of cancers um cancer cases in low middle income countries. And often when we look at the data in the context of low middle income countries, most people, so around 60 70% of people with cancer are presenting with quite late stages of disease. So advanced stages of disease and and that means there's limited treatment options. Uh They might have a range of symptoms, concerns and these could be, for example, physical such as pain or fatigue, but also psychological, social, spiritual. So my my role is really thinking about how digital health can support delivery of palliative care to support people with um with, with advanced cancer. And it's so it's so crucial to uh to, to have access to palliative care to enable, you know, good quality of life to address problematic symptoms. So really, that's been the focus of of, of my work today and a big problem across um low middle income countries.

Also the work we do in Sub Saharan Africa is access to palliative care. So thinking about how can people in urban, rural, you know, across countries, how can they access palliative care? Um when you've got very, very limited um provision of palliative care. Um so the multi country study, you mentioned um involved us working with a range of clinical and academic partners in three countries. So we did, we conducted the research in Nigeria, Uganda and bad way and we interviewed patients, carers, health professionals and policymakers to really understand and explore how um digital technology can support people with um advanced cancer. And and what we found from that work was that patients and carers really find digital technology an acceptable approach. So using that as a means of accessing palliative care, and we're particularly keen to see different ways of it being used. So this the from from our interviews with patients and carers, they were really keen to have sort of 24 hours seven access points to train professionals. So whether helplines, text messages, online chat without fear or concern that they'd be disturbing health professionals. Um So thinking about kind of triage um phone lines and other support lines, um they also wanted to um access and share details about their concerns um around cancer.

So any problematic symptoms they're having and they wanted to be able to share that and and quite practical things such as fact checking, drugs and lab tests that were ordered by health um health staff. So particularly um thinking about opioid supply and understanding whether pharmacies had opioids in stock um before going and getting a prescription pain is a really, really highly prevalent um symptom in, in, in uh people with advanced cancer. So we found lots and lots of different ways that it could be used. And and more recently, we've been applying some of those findings, particularly the desire to contact and share um patient patients being able to share their experiences and symptoms they're having with the clinical teams.

Um So picking up on the geo geographical point, um we've been doing some work in northern Uganda in a refugee settlement, uh the Bidi Bidi refugee settlement. Um And this settlement alone stretches over huge distances. It's hundreds of miles away from um Kampala, the capital in Uganda.

Um And, and it really provides a nice example about how you can kind of overcome geographical distances. So we've we've designed a a mobile application that's used by the village health team. So these are health workers based in the communities um across the refugee settlement.

And then village health team members use the mobile application to record information about symptoms, concerns that patients with advanced cancer report to them. And that information is then summarized and shared with clinical teams um in the refugee settlements. And that means the clinical teams can then review any continuous um or problematic symptoms and concerns that that arise, they can call and speak to the patient if they need to, they can respond with treatments interventions when they're necessary or they can also support the referrals that are needed out to larger health facilities outside of the um outside of the refugee settlement.

So that means that even though patients are living across broad massive geographical areas, the services are still able to identify problematic symptoms through routine assessment um that you know, a lot of these symptoms might otherwise be missed and people would be living with very, very complex difficult symptoms, um and a lot of distress associated with them.

And also it helps the co-ordination of care as well. So involving the clinical team, helping them to facilitate um uh any referrals that are needed out. And, and just the, the final point, really cosign was really, really important um as part of this process. And when we spoke to the clinical teams, when we were developing the intervention, um it, it, it, it, it showed that uh they told us that Hepatitis B and T and tuberculosis in particular were really highly prevalent in the camps. So it would be really helpful if the mobile application could capture not only symptoms and concerns related to advanced cancer, but also Hepatitis B and tuberculosis to, to help sort of save them time that they'd want to try and collect this data anyway. So, so that cosign process was really, really important. So we, we're just piloting that at the moment, patients are really um valuing the time they have now sitting down systematically discussing the symptoms with the health workers and the village health teams. Um And yeah, we, we, we're really sort of excited to see where, where the project goes next.

Yeah, so it, it's great to know that there are global partners, both clinical and academic that are investing in technology to sort of advance and improve access to cancer care. And so I'll go over to Professor Will. Uh so prof um we know that technology is and play an important role in enabling cancer care in lower and middle income countries. Recently, the Landside Ology Commission for Sub Saharan Africa, which you che highlighted the importance and the potential benefits of tele oncology with a clear cultural action for government and stakeholders to invest in tele oncology. So please, can you tell us more about this cultural

action? Sure. Uh Thank you very much for having me. I think um you know, internet. Uh I mean, telehealth is was one of the things that as the chair of the commission, we really thought that um you know, we know a lot of data that has shown the internet penetration into Africa, the mobile phone usage. Uh I believe when I saw some time, last time is a uh in Nigeria, over 51% internet penetration. And um and uh 84% of that mobile users, you know, to increase access to care. Um like Dr Matthew just mentioned, I think. Um so this was not even a debatable point uh in the call to action. So the call to action, we saw that telehealth can be a way for Africa to leapfrog into an era. I mean, I grew up in a village in, in, in, in Africa where, you know, uh we didn't have landlines, right? So, but now, you know, we have mobile phones. So we're talking about VR um, so if you can get that, you know, you can really increase access to patients, you know, in locations that, uh um otherwise they will not be able to because of geographic barriers.

And so, um, so this is what one of the, all the other calls to action. We had eight calls to action, there were seven of them, uh I mean, the first seven were familiar, you know, National Cancer Control Plans, all of that stuff. But I thought, um we thought it was really important to have because it's a really great opportunity for Africa. Uh Just one last thing, I mean, we know that, um, you know, I think it was the NIH um Fogo mentioned that, you know, um from the data that we have, you know, people may not have toilets in Africa but they do have mobile phones. They have, you know, you have a mom in the remote village who has whatsapp, right? So if they are sick, you know, you can do the symptom management, you can do the follow up, you can have consultation. Um And uh and so we've actually shown that it's gonna really, really work where, you know, um you can have somebody, um, you know, um you know, really, really access the best doctors in the world at the top institutions, you know, um not only in Nigeria or Africa where you want to have the doctors, but you know, uh the whole idea of brain drain and um and uh being able to access even the best specialist this from the UK Europe, a United States uh becomes possible.

And so this is a great opportunity. And so I'm very excited that I see uh companies like uh Uncle Pa and you know, you got the innovations that are being made. Uh As you remember when I heard you guys presented the U IC C, you are super excited about that. So,

thank you. Thank you so so much. Thank you for so well. So it's interesting to note that books because they sort of educated us on the fact that as much as ST oncology is very important, there's a call that really requires every stakeholder. So stakeholder engagement from the patients to the caregivers, to your loved ones, to family and friends, to government, to academic missions to researchers, technologies, engineers. It really is a global call for all types of partners. So Doctor Stella call over to you now.

Um I know I understand that Uncle Patty has launched two hops in the College of Medicine, University of Lagos and at the Olabisi Orano University Hospital. How are these hops, you know, generating insights and clinical services for cancer patients?

OK. Thank you so much for uh the question. And um it's a pleasure to be alongside pro lingua and uh Doctor Matthew and you Adam. And so our idea around the herbs is I is twofold. It's actually two pillars. Uh One pub is a research hub that is focused on generating evidence, generating data on how patients are using mobile apps or mobile based interventions for their health. Uh A as, as far back as uh six years ago, uh we i it was clear that cancer patients, especially in urban um cities, uh hospitals in urban cities that these patients were leveraging technology to source for information, to make some decisions. And we are lacking a lot of data on how patients are using the internet or mobile health interventions for their care. And so the hub at Onco Padi which is domiciled in the College of Medicine, University of Lagos is focused on reaching the gap one to promote mobile health research within the academic community. Uh Two to generate evidence on how we can you know, improve mobile health risk research and how patients are utilizing apps. Uh And it's also focused on how healthcare innovators within the academic community can specialize in digital health.

Uh Of course, we don't, we don't have digital health curriculums yet in many universities. So this hub is some form of uh a breach that exposes students and faculty members to research. And so the digital hub in the College of Medicine is um sort of a, you know, incubating, we used to call them divergence many years ago. But it's sort of identifying people who are interested in health tech who want to build products and we're sort of encouraging, promoting them, connecting them to resources to grants to networks. And, and we are saying, look, let's begin to generate evidence in diabetes, how apps can improve diabetic care, how we can and use technology to remotely monitor cancer patients and their side effects. After all, we know that cancer patients and many other patients spend a few hours in the clinic or spend a lot of time at home and in their communities. So how can we bridge this gap? And it's so important that the continent and other LM I must generate data so that we, we know how this work and how patients will benefit from it the most.

Um I I would say the research hub also at the College of Medicine is sort of an advocacy hub uh where we are trying to show the right way to go into digital health without dabbling or, or making mistakes as, as we do research and very, very strongly we are collaborating with um with experts like uh Matthew, with experts like will uh because in, in many parts of the world, they, they already have experience.

So it's not just us setting up a hub and doing things the way we want to. It's also about collaborating, OK, to peer learning and knowing which direction are we going towards. Now, we have started to generate some products and some papers which we will publish very soon. And the second hub is basically last mile. It's similar to what Matthew said earlier about. There are cancer patients in very remote locations and to Will's Point whilst they are in remote locations, they do have a mobile home. How can we serve them if they have a mobile phone in their hands, how can we provide adequate information? How can we tell them the right hospitals, doctors to see, how can we provide them with some clinical advice when they need it? And they don't have to travel 2 to 3 hours and spend maybe $10 just to see the doctor um and wait for maybe four hours to see the doctor and the doctor would, you know, just give them a clinical advice of 10 minutes. And so our hub at Ola Bion Banjo Teaching Hospital is, is a clinical hub. And through that clinic, uh through the hub, we run veal cancer clinics there. It's a state hospital. They have uh a fantastic cancer workforce. They have the surgeons, the radiologist, the pathologists, but they don't have the clinical oncologists. And we all know that you cannot provide quality cancer care in the absence of the complete team.

So with our hub, we are able to take in virtual oncologist into the hall with the cancer patients seated in the hub and we have a quick consultation in collaboration with the local surgeon, radiologists. So th th th those are the two hubs and what we do fantastic

fantastic work being done both globally and taking global perspective and translating it into global and local initiatives. Uh That's really interesting to note. So I think I'll just have, I just have one more question for Doctor Matthew because I know that you are for time.

Um So Doctor Matthew, I would like to learn a bit more on. Um What do you think would be the key take away for um people working in the cancer technology space. What's the one thing or one area that most innovators should focus on right now in improving access to cancer care?

Oh, there's lots of uh lots of, lots of things and challenges. I think, I think one of the key things and um uh uh Amala was saying a few times is data and I think what we have with digital technologies is the perfect data collection tool. I'm just thinking for advanced cancer patients. There are still lots of unknowns. We don't really understand which symptoms are most problematic when they occur, how they change over time. So these are really fundamental questions that we need to understand to design services that best meet the needs of patients. Um And so, so I think it's, it's, it's understanding how we can best use the data to inform development of services, particularly care for advanced cancer patients.

Um Yeah, that and then also, I guess as part of that it's using it for advocacy. Um you know, if we are highlighting a real need for service development. How can we best use data gathered by digital technology for advocacy? I think they're the, they're the kind of key areas for me really using that data. And uh yeah, capitalizing on it.

All right. Thank you so much, Doctor Matthew. Thank you. Uh So data being the focus of uh would you say the the future of digital health? Uh So doctor will um I know that you lead many impactful initiatives and one of them is the Comprehensive Cancer Center in the cloud, which is also data driven. And so can you share with us how this delivers last mile of cancer care to end users?

Sure. Yeah. And just to kind of uh put a framework on that, you know, the background on that. So, you know, it actually was one of the examples we highlighted in the Lancet Commission, the Comprehensive Cancer Center in the Cloud. And uh the whole idea is, you know, um if you imagine taking like the, the DNA, I have a cancer center or a cancer center in Lagos, um where you have the kind of multidisciplinary care that uh Doctor Omar just mentioned uh where they have that kind of care where everybody where patients can have comprehensive care, you know, from diagnosis, pre prevention, all the way to palliative care.

Um you know, noting that palliative care actually starts, can start from prevent from from the diagnosis. So um you know, but if you put that in the cloud, essentially, it means that, you know, uh if you have a phone from anywhere in the world or internet access, uh you can essentially um access cancer care services. Uh I mean, COVID-19 taught us that. In fact, the Lancet Commission we did was uh two years over during the period of COVID. And really what we are looking to do, one of the key recommendations which most countries have picked up on. Uh when we've launched this across Africa is, you know, we really have to invest in this telehealth um in information and communication technologies. Uh And now there are many countries that are looking at launching satellites to increase the penetration and stuff like that.

But what we really thought was if you can have that, you know, as we have this call to action to invest in telehealth. Um If you don't have a cancer center that's in the cloud, then basically, you know, patients can access that from anywhere in the world. It's a, it's kind of a vision. Uh But, you know, reality, we've actually had some really good results on that um beginning in the United States itself. So you talk about uh doctor mentioned about hubs. So, you know, think about putting a health care kiosk or hop in a church uh or in a religious um it could be in a mosque, right? So we know how much if you talk about last mile, you know, you know, how much, you know, we can do all the wonderful science that we have in the, at the top, top cancer centers or universities in the world about cancer or the best discoveries. But if they don't get to patients, um, they don't go that one last mile into the patients, uh to reach patients, then it doesn't mean anything. Give an example. So if you come up with the COVID vaccine, but you know, it doesn't get to the patient. Um you know, then uh it's almost like you wasted the money, right?

So, but if you go to uh if you can create those kiosk or hubs in churches, what that opportunity provides is that, you know, patients who are skeptical or who may otherwise due to transportation barriers, economic barriers, cultural barriers, uh mayor get screened, you know, right there and the information can be uploaded online, they can see a doctor directly when they leave church.

Uh really kind of bring holistic health care into um into those settings in the communities. So instead of waiting for the patients to come and present uh sometimes already with late disease, uh as we know, it is very common for minorities, including African Americans in the US and Latinos by the time they present it's late. Um So instead of waiting for them to come to the clinics, you basically take the clinics to their communities and um every community basically has a religious, most communities I say have a church or, or mosque. Um And so, working with these leaders who also have a lot of influence uh on whether this adoption of the new interventions uh becomes really important. Uh So in 4018, you know, uh we got this funding from the IBM uh $500,000 to kind of set up these um the cloud initiative. And uh it's been very successful in, you know, being able to provide that kind of uh access. Now, we just need to secure that. And I think that's part of the reason why we're looking at partnerships with organizations in Africa like you like. Uh because I think there, there's some really great opportunities there.

And lastly, I just want to mention that, you know, uh the importance of artificial intelligence with that. So I think, you know, the future right now is the war with artificial intelligence. Um It creates a tremendous opportunity where, you know, people can really have more higher quality care.

I mean, the, you know, as long as we have the appropriate regulations um in place for that. But um I think that that's the another place where as we invest in telehealth can really leapfrog is by investing in leveraging A I into this. So the Comprehensive Center in the cloud integrates that as well. So you can do remote treatment planning, remote monitoring e consultation. Uh You can do follow up, you know, you can uh send, send evidence based cancer prevention messages. Um you know, things like that. So that, that is the kind of uh uh vision that we have.

All right. All right,

fantastic uh work being done in the comp the Comprehensive Cancer Center in the Cloud uh is a very robust um center. And I think this is a call to all innovis here. Uh If you're working in cancer technologies, if you're working in digit in the Digital Oncology space, it will be important that you um plug into the Comprehensive Cancer Center in the Cloud. So I have, I actually have two questions here from our audience and I will just quickly go over to that. Um So the first question I have here is um from an anonymous person and the person asks, um does patient experience have a role to play in cancer care? And how uh so I'm sure this open to any of you to answer

maybe or more you go first and then now I leave it to you,

doctor. OK. So absolutely. Um if you build a product or service without the patient's um um the patient's contribution, uh then that product is likely to fail. And from our experience, our on COPA, we we started off as rookies building products without um understanding what the patient wanted, what their experience was like and what they really wanted to improve along the cancer continuum. So there are several problems that patients experience as they access treatment, you know, as they go back home. And whilst they are say, for example, 10 problems, uh one or two of them are present. So it's important that um whatever you are doing, you pull in the patient, the users, the end users of your product service and you understand their journey, the patient's journey from the beginning to the end. And you can do this, you know, through some of these focus group discussions, uh talk to the direct end users and then identify the secondary end users who sometimes are like the caregivers, the family and relatives of the patient, you know, extensively. I I it's almost like the parietal principle, like you have to spend 20% of your time planning and understanding the entire um thing. So patient experience is absolutely important. OK.

All right. Doctor will, would you like to add something to

that? Actually, that's, that's worth it.

All right. And so the next question here is how can African innovators plug into? So I think doctor will this question would really be most useful to you? So the question here is how can African innovators plug into data? And A I?

Yeah. Uh That's a good question. How can you do that? Um I think uh like the Lancet commission caught uh investing in telehealth that, that government really need to make, create those pathways, you know, to be able to plug into this they really need to create that enabling environment. Um You know, what do I mean by that? So I think, you know, as we, we, we uh experience A I currently and we still see when we're looking at telehealth in Africa, that there's a lot of gaps in terms of um one the regulatory landscape, you know, uh you know, in the US and Europe, you know, that's already well established, good and bad.

I mean, they are good sites in the sense that in Africa, right now, there's a great opportunity to because there are no rules, there are no rigorous rules uh about data sharing. I mean, people, most people don't really care as long as when you are accessing earth, whether you share their data, uh or not, we have to make those protections, those protections in place. But, um but right now, there's actually an opportunity where, you know, um you know, that we can really make sure that the governments um come in and invest into, you know, creating the data cloud platforms that, you know, can accommodate this data in a safe way uh in an ethical way.

Um And I think that uh chat GP T uh or A I in the sense has come up, has highlighted a big opportunity here where we can really tap in, everybody has access to it. Um And, and what that does is, you know, one way people can tap into that, you can basically, uh I think one easy way, this is one way that we actually uh started developing with the IBM was really where, you know, because of the access to evidence based cancer information that uh A I has, you can basically create these uh you know, I think you can have a mobile phone or, or uh or tablet where, you know, the, the A I can recommend to you the doctors.

And one of the things you mentioned at the beginning, uh Doctor Ada was the idea that uh the fact that um there are not a lot of oncologists, you know, um in different, different places in Africa or in communities in Nigeria, you know, some of those states do not have clinical oncologist.

Uh but what can happen is you can have A, I essentially make recommendations. Um And so, you know, what, what we're developing in the past was basically, if I put in the symptoms of the patient, uh you know, basically the A I can be able to read through all the clinical trials or the evidence base or the protocols and can be able to say, OK, based on these patients, uh symptoms or data, a diagnostic report here are the recommendations uh that you can make uh for treatment, you know, uh green, red, yellow, uh I mean, give you three suggestions and you, the doctor has to finally make the final decision.

But um but it gives you the second opinion essentially. Um Because sometimes you're by yourself, you're the doctor yourself in the clinic. And you're wondering, is this actually? Right? Uh What am I prescribing? Is it correct? You know, but the A I can give you that if uh support second opinion. Uh So I think that that's one area where it will be very useful. Uh Now there's the dangers, uh the misinformation and the things that, because A I only reads what's on the internet. Um So we have to be very careful about what, you know, it fits, you know, um fits us. So sometimes there may be, there may be need for, you know, that's why, I mean, the regulations that we need to be able to regulate some of the uh on how this is used. Um But uh there are tremendous opportunities now for people to use A I.

All right. Thank you so much. I chime in. Oh, yes, you can add.

Ok. So, and I think that very fantastic point made by Professor will uh the last six months, I felt overwhelmed by how A I is flourishing in health care. And if you're an innovator, you have to be alert to the trends. And in my mind, I'm like, ok, we're still trying to get this side of things, right? And now we have to sort of pay attention to A I so that you don't go extinct. And I'm like, oh, ok, like I might as a doctor, an oncologist in digital health, must I know how to, you know, code, what exactly do I want to use A I along the patient continuum? But to make myself feel comfortable and you know, come out of the overwhelm some of the strategies I'm adopting and I hope it will be useful to some people. Is one following a few thoughts, leaders in the A I health space, um identify a few of them, look at their content and it's, it's just like when you read from them, you get knowledgeable and you can apply it to your local setting. Uh The second thing is to join some very ethical A I health care groups, uh probably academic institutions, you know, who are focused on research and that way to will's point on ethics, you won't flout the rules.

And um I would say the third thing is around, you know, going for a course A I in health care. There are quite a lot of them right now on Coursera Emi that are quite affordable. Uh The pricey ones are provided by the Ivy League schools abroad, you know, and that's where I am at. Like we have to learn how to use A I otherwise we will go, you know, become extinct. Uh But at the same time, we mustn't be overwhelmed by, by A I OK.

Thank you so much. Doctor will. Thank you so much, Doctor Sako. So we are coming gradually to the close of our session. And I want you my speakers to leave my audience with one key takeaway from this session. What would you leave my audience with in one minute?

Uh Who goes?

OK. So I would say, um that I'll talk about the Onco Padi app, which is a friendly cancer app for cancer patients and their caregivers. We understand that uh when faced with cancer, you have to make a lot of decisions and we've developed the Onco Padi app to guide and navigate anyone dealing with cancer on the app, you can learn about cancer and how to cope, which is very important. Uh We have articles, we have blogs, we have the use which is like a cancer coaching program. Uh through the app, you can have your econs consultation or telemedicine consultation. If you need a second opinion from an oncologist or any cancer specialist, we have dieticians, nurses, oncologists on the app. Um You also, you know, if, if you, if you're on cancer treatment, radiotherapy chemotherapy, um you can report your side effects on this app so that uh doctors at our back end can you know, identify if you're having mild, moderate severe and they can provide you with clinical advice.

So if you know anyone dealing with cancer, please uh tell them to visit the WW dot Onco padi.com website. Thank

you. Thank you and doctor will

um I just reiterate the land commission call to action. Um Invest in telehealth uh which is really that governments, if you are government or your industry or you are in a space where uh you have the potential to invest into this. Um This is something that we should invest in, it's the future. Um you know, um there's gonna be a major return on that investment and, and for, for um for, for, for doctors. Um you know, the key message would be that, you know, you really need to do what uh Doctor Salako has mentioned, which is that you need to learn about A I and I mean, using information and communication technologies, I mean, you know, tele um uh COVID-19 taught us that, you know, you have to do it.

If you don't. Uh in the US, most doctors were hesitant about adopting technology, had to migrate to that. Uh Now with the, you know, with IG BT, it's even gonna be worse, you're going to be extinct like she said, if you don't learn. So uh that, that is the key message.

All right, thank you all so much. Thank you my amazing speakers and thank you all for staying with us to the end of this insightful, engaging and really practical session. Um Please describe to us um with an emoji using a slider link, um how you feel about the session and what you've learned from this session. And of course, if you know anyone who is dealing with cancer or you're caring for a cancer patient. You can create a free account on WW dot Ono padi.com or you can connect with us and the email. Follow us on socials on, on all our social media platforms at Ono Padi app. And if you would like to support the work we do, you can send us an email. Thank you all so much for your time until we meet again. It's been a wonderful, wonderful session having you all and thank you to my amazing speakers. Bye bye for me.